New @cphjournal.bsky.social special issue on decentring health systems out: journalhosting.ucalgary.ca/index.php/jcph featuring articles exploring how competing narratives, agency & resistance shape health policy & practice. Includes papers examining economic restructuring... 1/4

“DG SANTE’s continued pressure on health CSOs sends a worrying message. As the US experience shows, government–civil society partnerships are easy to break—restoring the value that they bring to policymaking is much harder.” @eleanorbrooks.bsky.social @hjarman.bsky.social @eupha.bsky.social

New article in @bmj Global Health with Emily Adrion and Jeff Collin: "Who funds the WHO Foundation? A transparency analysis of donation disclosures over the first 3 years of its operation" gh.bmj.com/content/10/7... @lhgp.bsky.social @uoe-sps.bsky.social

@jacktaggart.bsky.social and I have been working together on multistakeholderism, and thinking about how these hybrid forms of governance connect to multilateralism This is an attempt to think through institutional hybridity in global plastics governance www.globalpolicyjournal.com/articles/glo...

Remember Piepergate? The EU Commission officially ended today the position of EU SME Envoy, which was vacant since the resignation of Markus Pieper one year ago (below the new organisation chart of DG Grow, without the position) www.mlex.com/mlex/energy/...

EPHA and the University of Edinburgh have developed a series of explainers on the Better Regulation agenda. Find this and all resources on our dedicated page: epha.org/brbh-toolkit/ @eleanorbrooks.bsky.social @clemricherdel.bsky.social @ukri.org

𝐂𝐨𝐦𝐦𝐢𝐬𝐬𝐢𝐨𝐧 𝐏𝐫𝐞𝐬𝐢𝐝𝐞𝐧𝐭 𝐯𝐨𝐧 𝐝𝐞𝐫 𝐋𝐞𝐲𝐞𝐧'𝐬 𝐜𝐚𝐦𝐩𝐚𝐢𝐠𝐧 𝐨𝐧 𝐝𝐞𝐫𝐞𝐠𝐮𝐥𝐚𝐭𝐢𝐨𝐧𝐬 ➡️ 𝐖𝐞 𝐫𝐢𝐬𝐤 𝐚 𝐝𝐢𝐬𝐚𝐬𝐭𝐫𝐨𝐮𝐬 𝐡𝐚𝐥𝐟-𝐝𝐞𝐜𝐚𝐝𝐞 𝐨𝐟 𝐝𝐞𝐫𝐞𝐠𝐮𝐥𝐚𝐭𝐢𝐨𝐧, 𝐰𝐡𝐢𝐥𝐞 𝐜𝐥𝐢𝐦𝐚𝐭𝐞 𝐜𝐡𝐚𝐧𝐠𝐞 🌏 𝐞𝐧𝐯𝐢𝐫𝐨𝐧𝐦𝐞𝐧𝐭 🌳💧 𝐞𝐪𝐮𝐚𝐥𝐢𝐭𝐲 👥 & 𝐬𝐨𝐜𝐢𝐚𝐥 𝐫𝐢𝐠𝐡𝐭𝐬 ✊ 𝐚𝐫𝐞 𝐩𝐮𝐭 𝐨𝐧 𝐭𝐡𝐞 𝐛𝐚𝐜𝐤𝐛𝐮𝐫𝐧𝐞𝐫 – 𝐚𝐥𝐥 𝐢𝐧 𝐭𝐡𝐞 𝐧𝐚𝐦𝐞 𝐨𝐟 ‘𝐜𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞𝐧𝐞𝐬𝐬’. ✒ by Olivier Hoedeman @corporateeurope.bsky.social

LAUNCH: Today, we publish a toolkit for civil society, to support engagement with the Better Regulation agenda! You can find: 🔸Videos 🔸Explainers 🔸How Better Regulation processes affect health and much more! Access the toolkit now: lnkd.in/edKwMpGm

#Earlyview #Openaccess 'Impact Assessment as Agenda-Setting: Procedural Politicking and the Mobilization of Bias in the European Union's Audiovisual Media Services Directive' By @eleanorbrooks.bsky.social & @kat-lauber.bsky.social #RegGov #BetterRegulation onlinelibrary.wiley.com/doi/full/10....

Clean Industrial Deal risks becoming yet another example of corporate capture. Without strong transparency rules & enforcement, plus real accountability, industry will continue to write the EU’s agenda behind closed doors. ✊ We need #lobbyingfirewall to protect public interest decision-making!

Big business spends millions lobbying the EU, but who are the top spenders, and what do they want? Together with @lobbycontrol.bsky.social we took a look and can reveal that declared corporate lobby spend has reached unprecedented levels. #lobbying #lobbyingfirewall #corporatecapture

new paper with @jacktaggart.bsky.social in @gepjournal.bsky.social on corporate power, multistakeholderism and the Global Plastics Treaty we contend that multistakeholder partnerships constitute a key hedging strategy for companies facing regulatory pressures to address plastics pollution

2024 marked 70 years since the tobacco industry, faced with mounting evidence of the harm caused by its products, issued their “Frank Statement” to smokers reassuring them that the link between smoking and lung cancer was yet to be proven.🧵

Planned European Commission Recommendation on reducing #health / #cancer risk associated with sunbeds withdrawn yesterday ec.europa.eu/info/law/bet...

Strange developments re the EU's new #CriticalMedicinesAct. Widely considered the most important piece of health-related legislation announced for this mandate, but to have no impact assessment or genuine* public consultation, on the basis of its 'urgency'... 1/9

given that the USAID website has just gone offline, I feel it is profoundly misguided for public health experts to be giving this administration any credit whatsoever

Todays biggest story, I think. CEOs Vicky Cann has written a great report on industry lobbying in the EU against a universal PFAS ban. They are good at it - the lobbyists for the PFAS producers, the chem. industry, pharma industry and others. There's a risk very little will be done in coming years.

⏳ One week left to submit an abstract for our upcoming workshop on politics and health care/policy - deadline 21 Nov - feel free to get in touch with any questions. Full details below 👇

Perhaps of interest for @policyrelevant.bsky.social @kat-lauber.bsky.social @profkatsmith.bsky.social @merikoivusalo.bsky.social @centrehealthpolicy.bsky.social @paulcairney.bsky.social @twagnerrizvi.bsky.social

Fab opportunity to spend four days discussing all things political science and health - come join us in Prague in May 2025 - deadline for applications = 21 November. Full details and call for papers at www.linkedin.com/feed/update/...

This is a major challenge facing health - as well as social, environmental and labour - policy at EU level, and a key opportunity to work together to change the narrative on regulation 👇 #betterregulation

Yesterday the EU Ombudsman responded to our complaint about 🇪🇺 Commission’s Regulatory Scrutiny Board (RSB), its contacts with lobbyists, & whether it really has the full range of policy expertise needed for such an influential role. Original complaint ⤵️ corporateeurope.org/en/2023/03/e...

Worst fears confirmed with #draghireport on the next years priorities in the EU. What von der Leyen left vague is concretised. Key proposals will lead to a tighter corporate stranglehold over EU rules. 🧵Here are 4 examples:👇

European health policy starter pack My favourite European health policy and law connections on Bluesky so far go.bsky.app/K2JB6CN

new paper in BMJ Global Health on conceptualising the 'commercial determinants of health' with the brilliant Ellie Brooks and Charlotte Godziewski We highlight a tendency to overlook the importance of political institutions in shaping the exercise of corporate power gh.bmj.com/content/8/11...